Muhammad Mamdani

MPH, MA, PharmD

Director, Li Ka Shing Centre for Healthcare Analytics Research and Training (CHART)


Dr. Mamdani is the Director of the Li Ka Shing Centre for Healthcare Analytics Research and Training (CHART) of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital in Toronto. He is also Professor in the Leslie Dan Faculty of Pharmacy, the Department of Medicine of the Faculty of Medicine, and the Institute of Health Policy, Management and Evaluation of the Dalla Lana Faculty of Public Health. He is also adjunct Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES). Dr. Mamdani also is a member of the Human Drug Advisory Panel of the Patented Medicine Prices Review Board (PMPRB) and is a co-Principal Investigator of the Ontario Drug Policy Research Network. In 2010, Dr. Mamdani was named among Canada’s Top 40 under 40. Prior to joining the Li Ka Shing Knowledge Institute and St. Michael’s Hospital, Dr. Mamdani was a Director of Outcomes Research at Pfizer Global Pharmaceuticals in New York. Dr. Mamdani’s research interests include pharmacoepidemiology, pharmacoeconomics, and drug policy. He has published approximately 350 research studies in peer-reviewed medical journals, including leading journals such as the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association, the British Medical Journal, and Annals of Internal Medicine.

Dr. Mamdani obtained a Doctor of Pharmacy degree (PharmD) from the University of Michigan (Ann Arbor) in 1995 and subsequently completed a fellowship in pharmacoeconomics and outcomes research at the Detroit Medical Center in 1997. During his fellowship, Dr. Mamdani obtained a Master of Arts degree in Economics from Wayne State University in Detroit, Michigan. He then completed a Master of Public Health degree from Harvard University in 1998 with a concentration in quantitative methods, focusing on biostatistics and epidemiological principles.

Please note: Dr. Mamdani is not taking any summer students in 2018.




Recent Publications

  1. Verma, AA, Khuu, W, Tadrous, M, Gomes, T, Mamdani, MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study. PLoS Med. 2018;15 (6):e1002584. doi: 10.1371/journal.pmed.1002584. PubMed PMID:29889841 .
  2. Musselman, RP, Bennett, S, Li, W, Mamdani, M, Gomes, T, van Walraven, C et al.. Association between perioperative beta blocker use and cancer survival following surgical resection. Eur J Surg Oncol. 2018; :. doi: 10.1016/j.ejso.2018.05.012. PubMed PMID:29858097 .
  3. Antoniou, T, Macdonald, EM, Yao, Z, Gomes, T, Tadrous, M, Ho, JM et al.. A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride. BMC Musculoskelet Disord. 2018;19 (1):160. doi: 10.1186/s12891-018-2076-9. PubMed PMID:29789004 PubMed Central PMC5964967.
  4. Pasricha, SV, Tadrous, M, Khuu, W, Juurlink, DN, Mamdani, MM, Paterson, JM et al.. Clinical indications associated with opioid initiation for pain management in Ontario, Canada: A population-based cohort study. Pain. 2018; :. doi: 10.1097/j.pain.0000000000001242. PubMed PMID:29762260 .
  5. Gomes, T, Greaves, S, Tadrous, M, Mamdani, MM, Paterson, JM, Juurlink, DN et al.. Measuring the Burden of Opioid-related Mortality in Ontario, Canada. J Addict Med. 2018; :. doi: 10.1097/ADM.0000000000000412. PubMed PMID:29697503 .
  6. Tadrous, M, Brahmania, M, Martins, D, Knowles, S, Janssen, HLA, Mamdani, MM et al.. Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study. J Manag Care Spec Pharm. 2018;24 (5):464-468. doi: 10.18553/jmcp.2018.24.5.464. PubMed PMID:29694284 .
  7. Tadrous, M, Greaves, S, Martins, D, Mamdani, MM, Juurlink, DN, Gomes, T et al.. Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program. CMAJ Open. 2018;6 (1):E132-E138. doi: 10.9778/cmajo.20170132. PubMed PMID:29581101 PubMed Central PMC5878951.
  8. Vigod, SN, Bagheri, E, Zarrinkalam, F, Brown, HK, Mamdani, M, Ray, JG et al.. Online social network response to studies on antidepressant use in pregnancy. J Psychosom Res. 2018;106 :70-72. doi: 10.1016/j.jpsychores.2018.01.009. PubMed PMID:29455902 .
  9. Jayasundara, K, Krahn, M, Mamdani, M, Hoch, JS, Grootendorst, P. Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology. Pharmacoecon Open. 2017;1 (3):167-173. doi: 10.1007/s41669-017-0022-7. PubMed PMID:29441496 PubMed Central PMC5691840.
  10. Hussain, MA, Alali, AS, Mamdani, M, Tu, JV, Saposnik, G, Salata, K et al.. Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based study. J. Neurosurg. 2018; :1-8. doi: 10.3171/2017.8.JNS171142. PubMed PMID:29393758 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
  • Professor, Institute of Health Policy, Management, and Evaluation, University of Toronto
  • Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Adjunct Professor, King Saud University Senior Adjunct
  • Scientist, Institute for Clinical Evaluative Sciences